ALVO

アフターアワーズ： 8.43 0.405 +5.05%

Alvotech (ALVO)

概要ニュース株価時系列ディスカッション予測

Relative Volume:

ネットキャッシュフロー:

Alvotech Stock (ALVO) Company Profile

Healthcare (1157)

ALVO's Discussions on Twitter

ALVO を他の銘柄と比較する

株式	価格	時価総額	収益	当期純利益	現金流量	EPS
ALVO Alvotech	8.025	2.65B	391.87M	-441.45M	-301.21M	-1.85
ZTS Zoetis Inc	154.11	67.83B	9.39B	2.62B	2.22B	5.81
TAK Takeda Pharmaceutical Co Adr	15.00	46.74B	29.96B	957.25M	4.77B	0.304
HLN Haleon Plc Adr	9.65	43.52B	14.26B	1.98B	2.47B	0.4347
TEVA Teva Pharmaceutical Industries Ltd Adr	17.86	20.12B	16.54B	-1.64B	749.00M	-1.45
UTHR United Therapeutics Corp	313.13	14.11B	2.99B	1.21B	1.13B	25.06

Alvotech Stock (ALVO) Upgrades & Downgrades

日付	アクション	アナリスト	評価の変更
2025-02-14	開始されました	UBS	Buy
2024-01-29	アップグレード	Barclays	Equal Weight → Overweight
2023-10-20	アップグレード	Citigroup	Sell → Neutral
2023-09-21	開始されました	Barclays	Equal Weight
2022-09-07	開始されました	Morgan Stanley	Equal-Weight
2022-09-06	ダウングレード	Citigroup	Buy → Sell
2022-07-26	開始されました	Citigroup	Buy

Alvotech (ALVO) 最新ニュース

Alvotech (ALVO) 財務データ

Alvotech (ALVO)

Alvotech Stock (ALVO) Company Profile

ALVO を他の銘柄と比較する

Alvotech Stock (ALVO) Upgrades & Downgrades

Alvotech (ALVO) 最新ニュース

Bayer’s Eylea market grip set to slip as Alvotech biosimilar closes in - msn.com

Alvotech (NASDAQ:ALVO) Announces Earnings Results, Beats Estimates By $0.40 EPS - MarketBeat

Alvotech (NASDAQ:ALVO) Sees Strong Trading VolumeWhat's Next? - MarketBeat

Can Alvotech weather a recessionWeekly Gains Summary & Comprehensive Market Scan Reports - mustnews.co.kr

Alvotech Reports Strong H1 2025 Financials and Strategic Partnerships - MSN

Why Alvotech Shares Are Gaining Attention - TipRanks

Published on: 2025-08-16 00:15:42 - beatles.ru

Northland Securities Maintains Alvotech(ALVO.US) With Buy Rating, Maintains Target Price $28 - 富途牛牛

Alvotech (NASDAQ:ALVO) Shares Gap Up After Strong Earnings - MarketBeat

Alvotech Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

Alvotech shares fall 3.13% premarket after H1 2025 earnings call. - AInvest

Alvotech Reports Strong Growth and Strategic Expansion - TipRanks

Alvotech targets 50% U.S. Humira biosimilar market share by year-end as Q2 product revenues rise 77% - msn.com

Alvotech (ALVO) Expected to Announce Earnings on Wednesday - MarketBeat

Alvotech Reports Strong H1 2025 Financials and Strategic Partnerships. - AInvest

Alvotech's Q2 2025: Navigating Contradictions in Market Share, Revenue Guidance, and FDA Inspections - AInvest

Alvotech shares fall 11.44% intraday despite strong H1 2025 earnings and revenue growth. - AInvest

Alvotech Plunges 9.5% Intraday: Can This Biosimilars Powerhouse Rebound From Debt-Driven Volatility? - AInvest

Transcript : Alvotech, H1 2025 Earnings Call, Aug 14, 2025 - MarketScreener

Alvotech shares fall 2.34% premarket despite reporting strong H1 2025 earnings and product revenue growth. - AInvest

Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update - Placera.se

Alvotech shares rise 2.68% premarket after reporting strong Q2 2025 results and 200% product revenue growth. - AInvest

Alvotech's Q1 Operating Income Surpassing $28.6M: A Catalyst for Long-Term Growth in a High-Potential Biosimilars Sector? - AInvest

Alvotech Posts $28.6M H1 Operating Income, Product Revenue Rises - AInvest

Alvotech H1 operating income USD 28.639 million - MarketScreener

Alvotech (ALVO) Is Up 5.9% After Swinging to Profit in H1 2025What's Changed - simplywall.st

Alvotech's Strategic Transformation and Financial Turnaround: A High-Conviction Buy Opportunity in Biosimilars - AInvest

Alvotech (ALVO) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance

Why Alvotech Shares Are Under Pressure - TipRanks

Alvotech earnings beat by $0.50, revenue topped estimates - Investing.com Nigeria

ALVOTECH Earnings Results: $ALVO Reports Quarterly Earnings - Quiver Quantitative

Alvotech soars as product revenue surges over 200% YoY By Investing.com - Investing.com Australia

Alvotech soars as product revenue surges over 200% YoY - Investing.com India

Alvotech : Q2 2025Unaudited Condensed Consolidated Interim Financial Statements first 6 months - MarketScreener

Alvotech Reports Q2 Non-GAAP EPS of $0.49, Beating Estimates by $0.49, with Product Revenue Reaching $204.7 Million. - AInvest

Alvotech Reports Record Growth with 200% Increase in Product Revenues Year-on-Year and Best Quarter for Operating Cash Flows - Quiver Quantitative

Wall Street Analysts Think Alvotech (ALVO) Could Surge 102.31%: Read This Before Placing a Bet - sharewise.com

Why Alvotech stock attracts strong analyst attentionMarket Trend Summary & Fast Moving Market Watchlists - thegnnews.com

Alvotech to Report Q2 2025 Earnings on August 13, 2025, with Webcast on August 14, 2025 - AInvest

Alvotech's Q2 Earnings Preview: Analysts Expect $-0.11 EPS, Share Price Down 21.99% Over 52-Week Period - AInvest

Alvotech Rebounds From Oversold Zone — Now WhatAccurate Technical Trend Reversal Picks Detected - 선데이타임즈

Regression Model Predicts Rangebound Movement in AlvotechBuy Low Sell High Stock Watch Strategy in Focus - beatles.ru

MACD Signals Flash Warning for Alvotech StockLow Risk High Return Opportunities Identified - beatles.ru

Alvotech WRT ALVOW 2025Q2 Earnings Preview Upside Ahead on Revenue Growth Forecast - AInvest

What are Alvotech’s recent SEC filings showingAdvanced Entry Signal Stocks - thegnnews.com

Screener Results Flag Alvotech as OversoldCapital Preserving Trade Plan Templates Shared - metal.it

What makes Alvotech stock price move sharplyTop 100 Low Volatility Gainers - thegnnews.com

Who’s Hired? Rosemont Gains A Chairperson But Loses A CEO - insights.citeline.com

Earnings Preview: Alvotech to Report Financial Results Post-market on August 13 - 富途牛牛

Alvotech shares rise 1.89% after-hours following FDA approval of Ajovy for pediatric migraine prevention. - AInvest

Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 Am EDT - 富途牛牛

Alvotech (ALVO) 財務データ

収益

当期純利益

現金流量

EPS

ALVOに似た銘柄